EBV-induced fulminant hepatic failure: Favorable outcome after liver transplantation;Hépatite fulminante à virus Epstein-Barr: Évolution favorable après transplantation hépatique

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 8-9 C1, 2007, Pages 725-728

  Dumortier, Jérôme ^a   Mekki, Yahia ^a   Rimmelé, Thomas ^a   Ber, Charles ^a   Maillard, Emmanuel ^a   Fafi Kremer, Samira ^a   Lina, Bruno ^a   Scoazec, Jean Yves ^a   Delafosse, Bertrand ^a   Boillot, Olivier ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; PARACETAMOL; STEROID; TACROLIMUS;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADULT; ANEMIA; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; ECHOGRAPHY; ELECTROENCEPHALOGRAM; EPSTEIN BARR VIRUS; FEMALE; FEVER; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; POSTOPERATIVE PERIOD; SEROLOGY; TREATMENT OUTCOME;

EID: 34948841448     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(07)91934-X     Document Type: Article

References (6)

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481-92.
2. Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994;14:1-13.
3. Feranchak AP, Tyson RW, Narkewicz MR, Karrer FM, Sokol RJ. Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature. Liver Transpl Surg 1998;4:469-76.
4. Ader F, Chatellier D, Le Berre R, Morand P, Fourrier F. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject. Med Mal Infect 2006;36:396-8.
5. Yamamoto M, Kimura H, Hironaka T, Hirai K, Hasegawa S, Kuzushima K, et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol 1995;33:1765-8.
6. Gershburg E, Pagano JS. Epstein-Barr virus infections: prospects for treatment. J Antimicrob Chemother 2005;56:277-81.